Dublin – October 15, 2026 -- Elsevier has pledged 4,000 complimentary AI product licenses and an estimated €1m a year in in-kind support and funding to the European Commission's AI in Science Enablers Initiative.
The commitment was announced at the AI in Science Summit in Dublin. More than 1,000 participants from the research, technology, business and policy communities attended the event, which launched the Commission's effort to mobilize private-sector and philanthropic support for European science.
Elsevier splits 4,000 licenses evenly across four AI and clinical products
Elsevier will provide 1,000 licenses each for four products to European researchers, healthcare professionals and students:
- LeapSpace: a research-grade AI workspace for complex tasks across research workflows. The licenses go to early-career and senior researchers and are paired with a proposed Europe-wide Challenge to be developed with the Commission.
- ClinicalKey AI: an EHR- and API-enabled clinical decision support tool that surfaces the latest evidence at the point of care.
- ClinicalKey Nursing AI: a clinical AI tool for nurses, covering point-of-care decision-making and professional growth.
- Complete Anatomy: a 3D anatomy platform.
Elsevier commits about €1m a year to research collaborations and talent
The company will run at least three new collaborations per year with European research institutions. These draw on in-kind support from Elsevier's data science, ethics and software development experts, plus access to its content suite and knowledge discovery tools.
Elsevier will also take part in the Horizon-funded AIRIS project, which supports AI-enabled hypothesis generation in biomedicine.
It will establish a new Centre on Hybrid Intelligence for Trustworthy Research with the University of Amsterdam and Vrije Universiteit Amsterdam.
Elsevier will train approximately 10 PhD candidates, postdoctoral researchers and master's students in AI each year through programs across the company.
CEO Bayazit ties the pledge to trusted platforms for European researchers
Elsevier CEO Kumsal Bayazit said European researchers and clinicians working at the AI frontier need platforms and partnerships they can trust, and that the pledge brings the company's full capabilities to that effort.
Details remain open. Elsevier will keep working with the Commission in the weeks after the Summit to refine the pledge, including the scope of the LeapSpace Challenge.